Home  |  compounding

July 9, 2026

CCPA Submits Comments to FDA on Peptide Compounding

CCPA Submits Comments to FDA on Peptide Compounding The Chronic Care Policy Alliance (CCPA) submitted comments to the FDA’s Pharmacy…

Read More

April 2, 2026

The Mass Compounded GLP-1 Market Is Harming Patients.

For people living with the chronic disease of obesity, GLP-1 medications have been life-changing. Research shows that sustained use reduces…

Read More